Catechol-O-methyltransferase Inhibitors from Calendula officinalis Leaf

被引:2
|
作者
Kadowaki, Wataru [1 ]
Miyata, Ryo [1 ]
Fujinami, Misa [2 ]
Sato, Yoshizumi [2 ]
Kumazawa, Shigenori [1 ]
机构
[1] Univ Shizuoka, Grad Sch Integrated Pharmaceut & Nutr Sci, 52-1 Yada,Suruga Ku, Shizuoka 4228526, Japan
[2] Kisho Corp Co Ltd, 3-4-27 Kitasuna,Koto Ku, Tokyo 1360073, Japan
来源
MOLECULES | 2023年 / 28卷 / 03期
关键词
Calendula officinalis; flavonoid; phenylpropanoid; catechol-O-methyltransferase; Parkinson's disease; FLAVONOL GLYCOSIDES; TRITERPENE ALCOHOLS; PHENOLIC-COMPOUNDS; MARIGOLD; FLOWERS; CONSTITUENTS; EXTRACTS; ACID;
D O I
10.3390/molecules28031333
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Calendula officinalis is commonly known as marigold and its flowers are used in herbal medicines, cosmetics, perfumes, dyes, pharmaceutical preparations, and food products. However, the utility of its leaves has not been studied in depth. The purpose of the present study was to identify the major compounds in C. officinalis leaves and to determine the inhibitory properties of the isolated compounds toward human catechol-O-methyltransferase (COMT), a key neurotransmitter involved in Parkinson's disease and depression. We isolated and identified ten compounds, including two phenylpropanoids and seven flavonoids, from C. officinalis leaf extracts, of which four flavonoids were identified from C. officinalis leaves for the first time. Eight compounds exhibited COMT inhibitory activities with IC50 values of less than 100 mu M. Our results indicate that compounds in C. officinalis leaves are potentially effective for preventing Parkinson's disease and depression. Thus, C. officinalis leaves may hold promise as dietary supplements.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Inhibitors of Catechol-O-Methyltransferase
    Barrow, James C.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (03) : 324 - 332
  • [2] Monoamine oxidase and catechol-O-methyltransferase inhibitors
    Siderowf, A
    Kurlan, R
    MEDICAL CLINICS OF NORTH AMERICA, 1999, 83 (02) : 445 - +
  • [3] Nitrocatechol derivatives as inhibitors of catechol-O-methyltransferase
    Byrne, JM
    Tipton, KF
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1996, 24 (01) : S64 - S64
  • [4] Catechol-O-Methyltransferase Inhibitors Isolated From Thai Propolis
    Miyata, Ryo
    Motoyama, Tomoharu
    Nakano, Shogo
    Ito, Sohei
    Mukaide, Kazuma
    Vongsak, Boonyadist
    Kumazawa, Shigenori
    NATURAL PRODUCT COMMUNICATIONS, 2021, 16 (10)
  • [5] CATECHOL-O-METHYLTRANSFERASE
    FLOHE, L
    INTERNATIONAL PHARMACOPSYCHIATRY, 1974, 9 (01): : 52 - 60
  • [6] Catechol-O-Methyltransferase Inhibitors in Parkinson's Disease
    Mueller, Thomas
    DRUGS, 2015, 75 (02) : 157 - 174
  • [7] Inhibitors of catechol-O-methyltransferase sensitize mice to pain
    Kambur, O.
    Talka, R.
    Ansah, O. B.
    Kontinen, V. K.
    Pertovaara, A.
    Kalso, E.
    Mannisto, P. T.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (07) : 1553 - 1565
  • [8] 4-Hydroxybenzthiazole inhibitors of catechol-O-methyltransferase
    De Leon, Pablo
    Barrow, James
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [9] Design of novel inhibitors for the catechol-O-methyltransferase enzyme
    Cook, Emma
    Peterson, Larryn
    Cafiero, Mauricio
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [10] Catechol-O-methyltransferase inhibitors in Parkinson's disease
    Harper, J
    Vieira, B
    LANCET, 1998, 352 (9127): : 578 - 578